SHORT MINI-FUTURE - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 02:02:21 2024-06-28 pm EDT | ||
| 4.24 EUR | -0.47% |
|
| Current month | -0.47% | ||
| 1 month | -1.17% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 4.24 | -0.47% |
| 24-06-27 | 4.26 | +1.43% |
| 24-06-26 | 4.2 | -0.71% |
| 24-06-25 | 4.23 | +0.48% |
| 24-06-24 | 4.21 | -1.86% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 02:02 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Vontobel
|
| WKN | VX9XBT |
| ISIN | DE000VX9XBT6 |
| Date issued | 2022-04-07 |
| Strike | 87.33 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.52 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.37 € |
|---|---|
| Lowest since issue | 0.73 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.53
USD
Average target price
53.19
USD
Spread / Average Target
+28.09%
- Stock Market
- Certificates
- Certificat
